Citation Impact
Citing Papers
PHARMACOKINETIC AND PHARMACODYNAMIC ASPECTS OF THERAPY OF EXPERIMENTAL ENDOCARDITIS
1993
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Infective Endocarditis
2005 Standout
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Imaging beyond the proteome
2012 StandoutNobel
Molecular characterization of a 40 kDa OmpC-like porin from Serratia marcescens
1994
MOMP (major outer membrane protein) of Campylobacter jejuni; a versatile pore‐forming protein
2000
QM/MM Methods for Biomolecular Systems
2009 Standout
Linker‐insertion mutagenesis of Pseudomonas aeruginosa outer membrane protein OprF
1993
Industrial natural product chemistry for drug discovery and development
2013
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Big-Loop Recurrence within the Hippocampal System Supports Integration of Information across Episodes
2018 StandoutNobel
Sequence and relatedness in other bacteria of the Pseudomonas aeruginosa oprP gene coding for the phosphate‐specific porin P
1990
The hemifusion intermediate and its conversion to complete fusion: regulation by membrane composition
1995
The Campylobacter jejuni Porin Trimers Pack into Different Lattice Types when Reconstituted in the Presence of Lipid
1997
Burkholderia (formerly Pseudomonas) cepacia porin is an oligomer composed of two component proteins
1994
Glucan synthase inhibitors as antifungal agents
2001
Prosthetic-Joint Infections
2004 Standout
WF11899A, B and C, novel antifungal lipopeptides. I. Taxonomy, fermentation, isolation and physico-chemical properties.
1994
Antibiotics in Phase II and III Clinical Trials
2012
[17] Isolation of outer membranes
1994
Porin from the halophilic species Ectothiorhodospira vacuolata: cloning, structure of the gene and comparison with other porins
1997
A Selenium Analogue of Firefly D ‐Luciferin with Red‐Shifted Bioluminescence Emission
2012 StandoutNobel
New Lipoglycopeptides
2010
The bacterial porin superfamily: sequence alignment and structure prediction
1991
Microporous Organic Materials from Hydrophobic Dipeptides
2007
Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria
2006 StandoutNobel
Intrinsic antibiotic resistance: Mechanisms, origins, challenges and solutions
2013
Synthesis of Peptides and Pyrazines from β‐Amino Alcohols through Extrusion of H2 Catalyzed by Ruthenium Pincer Complexes: Ligand‐Controlled Selectivity
2011
De novo design of luciferases using deep learning
2023 StandoutNatureNobel
Orientation of porin channels in the outer membrane of Bordetella pertussis
1993
Photodynamic therapy for cancer
2003 Standout
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
2009 Standout
Distribution and resistance patterns ofHaemophilus influenzae: A European cooperative study
1988
Fungal ß(1,3)-D-glucan synthesis
2001
Seeing (and Using) the Light: Recent Developments in Bioluminescence Technology
2020
Management of multidrug-resistant enterococcal infections
2010
Bioluminescence and chemiluminescence in drug screening
2003
Bacterial biofilms: from the Natural environment to infectious diseases
2004 Standout
A Comparative Review of the Lipoglycopeptides: Oritavancin, Dalbavancin, and Telavancin
2009
Methicillin-Resistant Staphylococcus aureus
1989 Standout
The isolation and characterisation of a major outer-membrane protein from Bacteroides distasonis
1992
Characterization of an OprF-deficient mutant suggests that OprF is an essential protein for strain MF0
2000
Biomedical applications of bisphosphonates
2013
From natural products to clinically useful antifungals
2002
Influence of the lipid matrix on incorporation and function of LPS-free porin from Paracoccus denitrificans
1994
Naturally crystalline porin in the outer membrane of Bordetella pertussis
1988
Echinocandin antifungal drugs
2003 Standout
General and Specific Porins from Bacterial Outer Membranes
1998
Optical Monitoring and Treatment of Potentially Lethal Wound Infections In Vivo
2003
Revealing the Spatiotemporal Patterns of Bacterial Infectious Diseases Using Bioluminescent Pathogens and Whole Body Imaging
2001
Evidence for (lipo) oligosaccharides inBorrelia burgdorferiand their serological specificity
1991
The porins from the halophilic species Ectothiorhodospira shaposhnikovii and Ectothiorhodospira vacuolata
1996
Mycobacterium tuberculosis Rv3406 Is a Type II Alkyl Sulfatase Capable of Sulfate Scavenging
2013 StandoutNobel
Update on Infective Endocarditis
2006
Arborcandins A, B, C, D, E and F, Novel 1,3-.BETA.-Glucan Synthase Inhibitors. Production and Biological Activity.
2000
Noninvasive Optical Imaging of Firefly Luciferase Reporter Gene Expression in Skeletal Muscles of Living Mice
2001
Voltage gating of porins from Haemophilus influenzae type b
1994
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Photothermal Nanotherapeutics and Nanodiagnostics for Selective Killing of Bacteria Targeted with Gold Nanoparticles
2005
Antibacterial drug discovery in the resistance era
2016 StandoutNature
Refolded Outer Membrane Protein A of Escherichia coliForms Ion Channels with Two Conductance States in Planar Lipid Bilayers
2000
Cloning and expression of the major porin protein gene opcP of Burkholderia (formerly Pseudomonas) cepacia in Escherichia coli
1997
Bisphosphonate conjugation for bone specific drug targeting
2018
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
Evaluation of penicillin-based inhibitors of the class A and B β-lactamases from Bacillus anthracis
2003
Laminar fMRI and computational theories of brain function
2017
Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis.
1989 StandoutNobel
Targeted delivery to bone and mineral deposits using bisphosphonate ligands
2015
MOMP, a Divergent Porin from Campylobacter: Cloning and Primary Structural Characterization
2001
Purification, characterization and sequence analysis of Omp50,a new porin isolated from Campylobacter jejuni
2000
Remarkable Potential of the α-Aminophosphonate/Phosphinate Structural Motif in Medicinal Chemistry
2011
Exceptional Thermal Stability in a Supramolecular Organic Framework: Porosity and Gas Storage
2010 StandoutNobel
Semisynthesis of an Antifungal Lipopeptide Echinocandin
1999
Molecular characterization of the 28- and 31-kilodalton subunits of the Legionella pneumophila major outer membrane protein
1992
Aggregation‐Induced Emission: The Whole Is More Brilliant than the Parts
2014 Standout
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia
1996 Standout
Bacterial Infection in Chronic Obstructive Pulmonary Disease in 2000: a State-of-the-Art Review
2001
Efficacy of ceftazidime and aztreonam alone or in combination with amikacin in experimental left-sided Pseudomonas aeruginosa endocarditis
1993
The rare outer membrane protein, OmpL1, of pathogenic Leptospira species is a heat-modifiable porin
1995
Close Is Not Enough
2000 StandoutNobel
OmpA protein of Escherichia coli outer membrane occurs in open and closed channel forms.
1994
Noninvasive Optical Imaging Method To Evaluate Postantibiotic Effects on Biofilm Infection In Vivo
2004
Isolation and characterization of a conserved porin protein from Helicobacter pylori
1995
Reevaluation, using intact cells, of the exclusion limit and role of porin OprF in Pseudomonas aeruginosa outer membrane permeability
1992
Growth temperature dependence of channel size of the major outer-membrane protein (OprF) in psychrotrophic Pseudomonas fluorescens strains
1997
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
2003 Standout
Outer membrane proteins from Serratia marcescens
1993
Persistence mechanisms in Pseudomonas aeruginosa from cystic fibrosis patients undergoing ciprofloxacin therapy
1991
Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis
1988
Molecular characterization of the Serratia marcescens OmpF porin, and analysis of S. marcescens OmpF and OmpC osmoregulation
1997
A Strategy for the Selective Imaging of Glycans Using Caged Metabolic Precursors
2010 StandoutNobel
High-Level β-Lactam Resistance Associated with Acquired Multidrug Resistance in Helicobacter pylori
2003
Epitope mapping of the Pseudomonas aeruginosa major outer membrane porin protein OprF
1995
Bio- and chemiluminescence imaging in analytical chemistry
2005
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Porin activity and sequence analysis of a 31-kilodalton Treponema pallidum subsp. pallidum rare outer membrane protein (Tromp1)
1995
Applications of Acceptorless Dehydrogenation and Related Transformations in Chemical Synthesis
2013 StandoutScience
Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant
1992
Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase
1990
Copper-Catalyzed Synthesis of Mixed Alkyl Aryl Phosphonates
2014 StandoutNobel
LY303366 Exhibits Rapid and Potent Fungicidal Activity in Flow Cytometric Assays of Yeast Viability
1999
Noble Metals on the Nanoscale: Optical and Photothermal Properties and Some Applications in Imaging, Sensing, Biology, and Medicine
2008 Standout
Photodynamic Therapy with A Cationic Functionalized Fullerene Rescues Mice From Fatal Wound Infections
2010
Conservation of epitopes in the oligosaccharide portion of the lipooligosaccharide of Haemophilus influenzae type b
1987
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Outer membrane permeability in Pseudomonas cepacia: diminished porin content in a beta-lactam-resistant mutant and in resistant cystic fibrosis isolates
1988
Fluorescent Sensors for Measuring Metal Ions in Living Systems
2014 Standout
Existence and purification of porin heterotrimers of Escherichia coli K12 OmpC, OmpF, and PhoE proteins
1989
Identification of simple arylfluorosulfates as potent agents against resistant bacteria
2021 StandoutNobel
The Crisis in Antibiotic Resistance
1992 StandoutScience
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Imaging Tri-Fusion Multimodality Reporter Gene Expression in Living Subjects
2004 StandoutNobel
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
The C-Terminal Domain of the Bordetella pertussis Autotransporter BrkA Forms a Pore in Lipid Bilayer Membranes
1999
Porin activity of the native and recombinant outer membrane protein Oms28 of Borrelia burgdorferi
1996
Natural product and natural product derived drugs in clinical trials
2014 Standout
Further Insights into the Mode of Action of the Lipoglycopeptide Telavancin through Global Gene Expression Studies
2012
Large-Scale Applications of Transition Metal-Catalyzed Couplings for the Synthesis of Pharmaceuticals
2011 Standout
The role of outer membrane and efflux pumps in the resistance of gram-negative bacteria. Can we improve drug access?
1998
Lipopolysaccharide tightly bound to porin monomers and trimers from Escherichia coli K-12
1987
Rapid Control of Wound Infections by Targeted Photodynamic Therapy Monitored by In Vivo Bioluminescence Imaging¶
2002
On the Ionization State of the Substrate in the Active Site of Glutamate Racemase. A QM/MM Study about the Importance of Being Zwitterionic
2005
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)
1997
Electrogenerated Chemiluminescence and Its Biorelated Applications
2008 Standout
Insertion mutagenesis of the Pseudomonas aeruginosa phosphate-specific porin OprP
1995
In Vitro Activities of a New Lipopeptide Antifungal Agent, FK463, against a Variety of Clinically Important Fungi
2000
Conformational analysis of the Campylobacter jejuni porin
1995
Imaging Cell Surface Glycans with Bioorthogonal Chemical Reporters
2007 StandoutNobel
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Advances in In Vivo Bioluminescence Imaging of Gene Expression
2002
The Oms66 (p66) protein is a Borrelia burgdorferi porin
1997
The C-Terminal Domain of Salmonella enterica Serovar Typhimurium OmpA Is an Immunodominant Antigen in Mice but Appears To Be Only Partially Exposed on the Bacterial Cell Surface
2003
Noninvasive biophotonic imaging for studies of infectious disease
2010
Effects of alginase on the natural history and antibiotic therapy of experimental endocarditis caused by mucoid Pseudomonas aeruginosa
1992
Modification of penicillin-binding proteins as mechanisms of beta-lactam resistance
1986
Ligand-Specific Opening of a Gated-Porin Channel in the Outer Membrane of Living Bacteria
1997 Science
Roles of the Carboxy-Terminal Half of Pseudomonas aeruginosa Major Outer Membrane Protein OprF in Cell Shape, Growth in Low-Osmolarity Medium, and Peptidoglycan Association
1998
Challenges of Antibacterial Discovery
2011
Isolation and characterization of a family of porin proteins from Helicobacter pylori
1995
Advancing Molecular Therapies through In Vivo Bioluminescent Imaging
2003
Identification of a Bordetella pertussis bvg-regulated porin-like protein
1995
Real-Time Bioluminescence Imaging of Glycans on Live Cells
2010 StandoutNobel
Inorganic Nanoparticles for MRI Contrast Agents
2009 Standout
Identification and characterization of porins in Pseudomonas aeruginosa.
1991
Sequence Polymorphism, Predicted Secondary Structures, and Surface-Exposed Conformational Epitopes of Campylobacter Major Outer Membrane Protein
2000
Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase
1994
Construction and Validation of Improved Triple Fusion Reporter Gene Vectors for Molecular Imaging of Living Subjects
2007 StandoutNobel
Molecular Epidemiology of Antibiotic Resistance Plasmids of Haemophilus Species and Neisseria gonorrhoeae
1986
Works of Thomas Parr being referenced
Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium
2009
Activity of oritavancin and comparators in vitro against standard and high inocula of Staphylococcus aureus
2011
Mechanisms of Aminoglycoside Resistance in Variants of Pseudomonas aeruginosa Isolated During Treatment of Experimental Endocarditis in Rabbits
1988
Correlation of cilofungin in vivo efficacy with its activity againstAspergillus fumigatus(1,3)-β-d-glucan synthase
1993
Bisphosphonated fluoroquinolone esters as osteotropic prodrugs for the prevention of osteomyelitis
2008
Oritavancin Exhibits Dual Mode of Action to Inhibit Cell-Wall Biosynthesis in Staphylococcus aureus
2008
Synthesis and in vitro evaluation of bisphosphonated glycopeptide prodrugs for the treatment of osteomyelitis
2010
Persistence of Pseudomonas aeruginosa during ciprofloxacin therapy of a cystic fibrosis patient: transient resistance to quinolones and protein F-deficiency
1990
Vancomycin and Oritavancin Have Different Modes of Action in Enterococcus faecium
2009
Bisphosphonated Benzoxazinorifamycin Prodrugs for the Prevention and Treatment of Osteomyelitis
2008
Characterization of a rabbit model of staphylococcal osteomyelitis
1997
The graphical brain: Belief propagation and active inference
2017
Characterization and cilofungin inhibition of solubilized Aspergillus fumigatus (1,3)-beta-D-glucan synthase
1994
Systemic Antibacterial Activity of Novel Synthetic Cyclic Peptides
2005
Lipopolysaccharide banding patterns of Neisseria meningitidis and Neisseria gonorrhoeae
1984
Molecular basis of the non-beta-lactamase-mediated resistance to beta-lactam antibiotics in strains of Haemophilus influenzae isolated in Canada
1992
Effect of Polysorbate 80 on Oritavancin Binding to Plastic Surfaces: Implications for Susceptibility Testing
2008
Direct Continuous Method for Monitoring Biofilm Infection in a Mouse Model
2003
Oritavancin Disrupts Membrane Integrity of Staphylococcus aureus and Vancomycin-Resistant Enterococci To Effect Rapid Bacterial Killing
2010
Assessment by Time-Kill Methodology of the Synergistic Effects of Oritavancin in Combination with Other Antimicrobial Agents against Staphylococcus aureus
2008
Lipopolysaccharide composition of three strains of Haemophilus influenzae
1984
Outer membrane porin protein ofCampylobacter jejuni
1986
Bordetella pertussis major outer membrane porin protein forms small, anion-selective channels in lipid bilayer membranes
1986
Bactericidal interactions of a beta-lactam and beta-lactamase inhibitors in experimental Pseudomonas aeruginosa endocarditis caused by a constitutive overproducer of type Id beta-lactamase
1987
W-1 solubilization and kinetics of inhibition by cilofungin of Candida albicans (1,3)-beta-D-glucan synthase
1991
Expression in Escherichia coli and function of Pseudomonas aeruginosa outer membrane porin protein F
1986
Pharmacodynamics of Oritavancin (LY333328) in a Neutropenic-Mouse Thigh Model of Staphylococcus aureus Infection
2003
Oritavancin Kills Stationary-Phase and BiofilmStaphylococcus aureusCells In Vitro
2008
Comparative In Vitro Activity Profile of Oritavancin against Recent Gram-Positive Clinical Isolates
2009
Modes of action and inhibitory activities of new siderophore-beta-lactam conjugates that use specific iron uptake pathways for entry into bacteria
1992
Lipopolysaccharide-free Escherichia coli OmpF and Pseudomonas aeruginosa protein P porins are functionally active in lipid bilayer membranes
1986
Role of beta-lactamase in in vivo development of ceftazidime resistance in experimental Pseudomonas aeruginosa endocarditis
1987
Validation of a Noninvasive, Real-Time Imaging Technology Using Bioluminescent Escherichia coli in the Neutropenic Mouse Thigh Model of Infection
2001
Linking Bisphosphonates to the Free Amino Groups in Fluoroquinolones: Preparation of Osteotropic Prodrugs for the Prevention of Osteomyelitis
2008
Role of porins in intrinsic antibiotic resistance of Pseudomonas cepacia
1987
4-Substituted d -Glutamic Acid Analogues: The First Potent Inhibitors of Glutamate Racemase (MurI) Enzyme with Antibacterial Activity
2002
Epidemiological typing of Moraxella catarrhalis by using DNA probes
1993
Isolation of the outer membrane and characterization of the major outer membrane protein from Spirochaeta aurantia
1987
Phosphate-selective porins from the outer membranes of fluorescent Pseudomonas sp.
1987
Outer membrane and porin characteristics of Serratia marcescens grown in vitro and in rat intraperitoneal diffusion chambers
1990
Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics
1984